LAG-3 expression in the inflammatory microenvironment of glioma

PURPOSE: Immune modulatory therapies including immune checkpoint inhibitors have so far failed to result in clinically meaningful efficacy in glioma. We aimed to investigate lymphocyte activation gene 3 (LAG-3), an inhibitory receptor on immune cells and target of second-generation immune checkpoint...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neurooncol
Egile Nagusiak: Mair, Maximilian J., Kiesel, Barbara, Feldmann, Katharina, Widhalm, Georg, Dieckmann, Karin, Wöhrer, Adelheid, Müllauer, Leonhard, Preusser, Matthias, Berghoff, Anna S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer US 2021
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8084780/
https://ncbi.nlm.nih.gov/pubmed/33651248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-021-03721-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak